Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nightingale.ai is a Toronto-based digital health company that provides an AI-powered platform for remote physical therapy and rehabilitation management. Founded by a team of clinicians and engineers from the University of Toronto, the company leverages vision-based artificial intelligence to analyze patient movements and surgical recovery, specifically for individuals undergoing hip and knee replacements. The platform enables physiotherapists to monitor patient progress remotely, automate functional assessments, and personalize treatment plans, aiming to improve clinical outcomes while reducing the cost of care. Nightingale.ai's technology integrates computer vision to track body mechanics and provide objective data for clinical decision-making, facilitating more frequent interaction between providers and patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nightingale.ai.